Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides.
Rupoli S, Goteri G, Pulini S, Filosa A, Tassetti A, Offidani M, Filosa G, Mozzicafreddo G, Giacchetti A, Brandozzi G, Cataldi I, Barulli S, Ranaldi R, Scortechini AR, Capretti R, Fabris G, Leoni P; Marche Regional Multicentric Study Group of Cutaneous Lymphomas. Rupoli S, et al. Eur J Haematol. 2005 Aug;75(2):136-45. doi: 10.1111/j.1600-0609.2005.00497.x. Eur J Haematol. 2005. PMID: 16000130 Clinical Trial.
Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.
Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Tassetti A, Scortechini AR, Offidani M, Mulattieri S, Stronati A, Brandozzi G, Giacchetti A, Mozzicafreddo G, Ricotti G, Filosa G, Bettacchi A, Simonacci M, Novelli N, Leoni P. Pulini S, et al. Among authors: rupoli s. Haematologica. 2007 May;92(5):686-9. doi: 10.3324/haematol.10879. Haematologica. 2007. PMID: 17488695 Free article. Clinical Trial.
Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides.
Rupoli S, Canafoglia L, Goteri G, Leoni P, Brandozzi G, Federici I, Micucci G, Giantomassi F, Mozzicafreddo G, Alterini R, Filosa G, Ricotti G, Simonacci M, Scortechini AR, Zizzi A, Pimpinelli N. Rupoli S, et al. Eur J Dermatol. 2016 Jan-Feb;26(1):13-20. doi: 10.1684/ejd.2015.2672. Eur J Dermatol. 2016. PMID: 26678311 Clinical Trial.
Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.
Rupoli S, Barulli S, Guiducci B, Offidani M, Mozzicafreddo G, Simonacci M, Filosa G, Giacchetti A, Ricotti G, Brandozzi G, Cataldi I, Serresi S, Ceschini R, Bugatti L, Offidani A, Giangiacomi M, Brancorsini D, Leoni P. Rupoli S, et al. Haematologica. 1999 Sep;84(9):809-13. Haematologica. 1999. PMID: 10477454 Clinical Trial.
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.
Offidani M, Corvatta L, Marconi M, Visani G, Alesiani F, Brunori M, Galieni P, Catarini M, Burattini M, Centurioni R, Rupoli S, Scortechini AR, Giuliodori L, Candela M, Capelli D, Montanari M, Olivieri A, Piersantelli MN, Leoni P. Offidani M, et al. Among authors: rupoli s. Haematologica. 2006 Jan;91(1):133-6. Haematologica. 2006. PMID: 16434383 Clinical Trial.
Prognostic markers in mycosis fungoides.
Goteri G, Rupoli S, Pulini S, Tassetti A, Leoni P. Goteri G, et al. Among authors: rupoli s. Anal Quant Cytol Histol. 2008 Aug;30(4):187-9. Anal Quant Cytol Histol. 2008. PMID: 18773735 No abstract available.
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Bettacchi A, Mulattieri S, Picardi P, Tassetti A, Scortechini AR, Fioritoni G, Leoni P. Pulini S, et al. Among authors: rupoli s. Eur J Haematol. 2009 Mar;82(3):184-93. doi: 10.1111/j.1600-0609.2008.01197.x. Eur J Haematol. 2009. PMID: 19215609 Clinical Trial.
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints.
Rupoli S, Goteri G, Morsia E, Torre E, Giantomassi F, Campanati A, Offidani AM, Molinelli E, Brandozzi G, Serresi S, Giacchetti A, Bugatti L, Filosa G, Mozzicafreddo G, Simonacci M, Olivieri A. Rupoli S, et al. Dermatol Ther. 2022 Oct;35(10):e15737. doi: 10.1111/dth.15737. Epub 2022 Aug 9. Dermatol Ther. 2022. PMID: 35903895
99 results